SMC publishes a Collaborative Advice Document for tixagevimab-cilgavimab (Evusheld) for prevention of COVID-19

14 June 2023 - SMC has collaborated with NICE on Technology Appraisal, TA900: tixagevimab-cilgavimab for preventing COVID-19. ...

Read more →

Chiesi’s Trimbow recommended for use within NHS Scotland

18 August 2022 - The SMC approval brings much needed boost to asthma sufferers across Scotland. ...

Read more →

Scottish approval of a new treatment for people with chronic obstructive pulmonary disease - formoterol fumarate dihydrate/glycopyrronium bromide/budesonide

8 February 2021 - AstraZeneca today announced that Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) is now accepted for use by the SMC ...

Read more →

‘Not acceptable’ disappointment as cystic fibrosis drug not approved in Scotland

12 August 2019 - People with cystic fibrosis in Scotland will continue to be denied potentially life-extending drugs after they ...

Read more →

Cystic fibrosis drugs rejected for use by NHS in Scotland

12 August 2019 - Two "life-changing" cystic fibrosis drugs have been rejected for routine use by the NHS in Scotland. ...

Read more →

Cystic fibrosis patient backs campaign to make medicines available on NHS

10 June 2018 - A cystic fibrosis patient is calling for a medicine to be made available on the NHS ...

Read more →

People at risk of HIV in Scotland to be given PrEP drug on NHS

11 April 2017 - AIDS campaigners say move puts pressure on England to end delays in providing the medication despite two ...

Read more →